Bahl & Gaynor’s Humana HUM Stock Holding History

Bahl & Gaynor’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,145	Closed	-$206K	–	397
2016 Q2	$206K	Hold	1,145	–	–	﹤0.01%	388
2016 Q1	$209K	Sell	1,145 -138	-11%	-$23.9K	﹤0.01%	396
2015 Q4	$229K	Buy	+1,283	New	+$225K	﹤0.01%	399

Other funds holding HUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ETC

Evercore Trust Company New York $34.6B AUM 25.41% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bahl & Gaynor's HUM Position: Q3 2016 in Review

Bahl & Gaynor sold out of Humana (HUM) in Q3 2016, closing a stake of 1,145 shares — an estimated $206K sold.

Bahl & Gaynor first reported a position in HUM in Q4 2015 and held it in 3 quarters. The position peaked at $229K in Q4 2015. 571 funds tracked by Wall St. Rank hold HUM as of Q3 2016.

Bahl & Gaynor reported no remaining Humana position as of Q3 2016 after selling out during the quarter.
Bahl & Gaynor sold 1,145 Humana shares in Q3 2016, an estimated $206K.
Bahl & Gaynor first reported a position in Humana in Q4 2015 and held it in 3 quarters.
Bahl & Gaynor's Humana position peaked at $229K in Q4 2015.
571 funds tracked by Wall St. Rank held Humana as of Q3 2016.

Based on Bahl & Gaynor's 13F filing for Q3 2016, filed 7 Nov 2016.